Literature DB >> 21982749

Sgp3 and Sgp4 control expression of distinct and restricted sets of xenotropic retroviruses encoding serum gp70 implicated in murine lupus nephritis.

Masao Kihara1, Valérie Leroy, Lucie Baudino, Leonard H Evans, Shozo Izui.   

Abstract

The envelope glycoprotein gp70 of endogenous retroviruses implicated in murine lupus nephritis is secreted by hepatocytes and its expression is controlled by Sgp3 (serum gp70 production 3) and Sgp4 loci derived from lupus-prone mice. Among three different endogenous retroviruses (ecotropic, xenotropic and polytropic), xenotropic viruses are considered to be the major source of serum gp70. Although the abundance of xenotropic viral gp70 RNA in livers was up-regulated by the presence of these two Sgp loci, it has not yet been clear whether Sgp3 and Sgp4 regulate the expression of a fraction or multiple xenotropic viruses present in mouse genome. To address this question, we determined the genetic origin of xenotropic viral sequences expressed in wild-type and two different Sgp congenic C57BL/6 mice. Among 14 xenotropic proviruses present in the C57BL/6 genome, only two proviruses (Xmv10 and Xmv14) were actively transcribed in wild-type C57BL/6 mice. In contrast, Sgp3 enhanced the transcription of Xmv10 and induced the transcription of three additional xenotropic viruses (Xmv15, Xmv17 and Xmv18), while Sgp4 induced the expression of a different xenotropic virus (Xmv13). Notably, stimulation of TLR7 in Sgp3 congenic C57BL/6 mice led to a highly enhanced expression of potentially replication-competent Xmv18. These results indicated that Sgp3 and Sgp4 independently regulated the transcription of distinct and restricted sets of xenotropic viruses in trans, thereby promoting the production of nephritogenic gp70 autoantigens. Furthermore, the induced expression of potentially replication-competent xenotropic viruses by Sgp3 may contribute to the development of autoimmune responses against gp70 through the activation of TLR7. 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21982749      PMCID: PMC3254601          DOI: 10.1016/j.jaut.2011.09.001

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  56 in total

1.  Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus.

Authors:  P Blanco; A K Palucka; M Gill; V Pascual; J Banchereau
Journal:  Science       Date:  2001-11-16       Impact factor: 47.728

2.  Genetic control of glycoprotein 70 autoantigen production and its influence on immune complex levels and nephritis in murine lupus.

Authors:  R M Tucker; T J Vyse; S Rozzo; C L Roark; S Izui; B L Kotzin
Journal:  J Immunol       Date:  2000-08-01       Impact factor: 5.422

3.  Autoantigen glycoprotein 70 expression is regulated by a single locus, which acts as a checkpoint for pathogenic anti-glycoprotein 70 autoantibody production and hence for the corresponding development of severe nephritis, in lupus-prone PXSB mice.

Authors:  M E Haywood; T J Vyse; A McDermott; E M Thompson; A Ida; M J Walport; S Izui; B J Morley
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

4.  The Sgp3 locus derived from the 129 strain is responsible for enhanced endogenous retroviral expression in macroH2A1-deficient mice.

Authors:  Lucie Baudino; Lakshmi N Changolkar; John R Pehrson; Shozo Izui
Journal:  J Autoimmun       Date:  2010-09-15       Impact factor: 7.094

5.  Regulator of sex-limitation (Rsl) encodes a pair of KRAB zinc-finger genes that control sexually dimorphic liver gene expression.

Authors:  Christopher J Krebs; Leslie K Larkins; Ryan Price; Kathryn M Tullis; Raymond D Miller; Diane M Robins
Journal:  Genes Dev       Date:  2003-10-16       Impact factor: 11.361

6.  The Sgp3 locus on mouse chromosome 13 regulates nephritogenic gp70 autoantigen expression and predisposes to autoimmunity.

Authors:  Catherine Laporte; Benoît Ballester; Charles Mary; Shozo Izui; Luc Reininger
Journal:  J Immunol       Date:  2003-10-01       Impact factor: 5.422

7.  Activation of autoreactive B cells by CpG dsDNA.

Authors:  Gregory A Viglianti; Christina M Lau; Timothy M Hanley; Benjamin A Miko; Mark J Shlomchik; Ann Marshak-Rothstein
Journal:  Immunity       Date:  2003-12       Impact factor: 31.745

8.  Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration.

Authors:  Mathias Heikenwalder; Magdalini Polymenidou; Tobias Junt; Christina Sigurdson; Hermann Wagner; Shizuo Akira; Rolf Zinkernagel; Adriano Aguzzi
Journal:  Nat Med       Date:  2004-01-25       Impact factor: 53.440

9.  Tropism, cytotoxicity, and inflammatory properties of two envelope genes of murine leukemia virus type-endogenous retroviruses of C57BL/6J mice.

Authors:  Young-Kwan Lee; Alex Chew; David G Greenhalgh; Kiho Cho
Journal:  Mediators Inflamm       Date:  2011-06-05       Impact factor: 4.711

10.  Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice.

Authors:  Marie-Laure Santiago-Raber; Roberto Baccala; Katarina M Haraldsson; Divaker Choubey; Timothy A Stewart; Dwight H Kono; Argyrios N Theofilopoulos
Journal:  J Exp Med       Date:  2003-03-17       Impact factor: 14.307

View more
  3 in total

1.  Sgp3 and TLR7 stimulation differentially alter the expression profile of modified polytropic retroviruses implicated in murine systemic lupus.

Authors:  Valérie Leroy; Masao Kihara; Lucie Baudino; Guy Brighouse; Leonard H Evans; Shozo Izui
Journal:  J Autoimmun       Date:  2012-04-13       Impact factor: 7.094

2.  Three Sgp loci act independently as well as synergistically to elevate the expression of specific endogenous retroviruses implicated in murine lupus.

Authors:  Kiyoaki Ito; Lucie Baudino; Masao Kihara; Valérie Leroy; Timothy J Vyse; Leonard H Evans; Shozo Izui
Journal:  J Autoimmun       Date:  2013-03-07       Impact factor: 7.094

3.  The Lupus Susceptibility Locus Sgp3 Encodes the Suppressor of Endogenous Retrovirus Expression SNERV.

Authors:  Rebecca S Treger; Scott D Pope; Yong Kong; Maria Tokuyama; Manabu Taura; Akiko Iwasaki
Journal:  Immunity       Date:  2019-01-29       Impact factor: 31.745

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.